https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
001) than non-switchers (N=31,644). Switchers reached the median for IP admission (21.50 months) vs non-switchers (not reached) and for ER visits (switchers, 9.07 months; non-switchers, 13.35 months). For disease relapse, other psychiatric relapse, and EPS diagnosis, less then 50% of patients had an event during the 2-year study period. Comparisons in a subgroup of patients with ≥1 EPS diagnosis revealed similar outcomes. CONCLUSIONS These results show that disease and other psychiatric relapse, all-cause ER visits, IP
Like
Comment
Share
